Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Drug Repurposing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drug Repurposingmarket, defines the market attractiveness level of Drug Repurposing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drug Repurposing industry, describes the types of Drug Repurposing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drug Repurposing market and the development prospects and opportunities of Drug Repurposing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drug Repurposing market in Chapter 13.
By Player:
Allergan
Novartis
Pfizer
Biovista
NuMedii
Astellas Pharma
AbbVie
By Type:
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drug Repurposing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drug Repurposing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drug Repurposing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drug Repurposing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drug Repurposing Market Analysis and Outlook to 2022
-
7.1 Global Drug Repurposing Consumption (2017-2022)
-
7.2 United States Drug Repurposing Consumption (2017-2022)
-
7.3 Europe Drug Repurposing Consumption (2017-2022)
-
7.4 China Drug Repurposing Consumption (2017-2022)
-
7.5 Japan Drug Repurposing Consumption (2017-2022)
-
7.6 India Drug Repurposing Consumption (2017-2022)
-
7.7 South Korea Drug Repurposing Consumption (2017-2022)
8 Region and Country-wise Drug Repurposing Market Analysis and Outlook to 2028
-
8.1 Global Drug Repurposing Consumption Forecast (2022-2028)
-
8.2 United States Drug Repurposing Consumption Forecast (2022-2028)
-
8.3 Europe Drug Repurposing Consumption Forecast (2022-2028)
-
8.4 China Drug Repurposing Consumption Forecast (2022-2028)
-
8.5 Japan Drug Repurposing Consumption Forecast (2022-2028)
-
8.6 India Drug Repurposing Consumption Forecast (2022-2028)
-
8.7 South Korea Drug Repurposing Consumption Forecast (2022-2028)
9 Global Drug Repurposing Market Outlook by Types and Applications to 2022
-
9.1 Global Drug Repurposing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CNS Diseases Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Drug Repurposing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Drug Repurposing Market Outlook by Types and Applications to 2028
-
10.1 Global Drug Repurposing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drug Repurposing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Drug Repurposing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drug Repurposing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drug Repurposing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drug Repurposing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drug Repurposing Market Competitive Analysis
-
14.1 Allergan
-
14.1.1 Allergan Company Details
-
14.1.2 Allergan Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan Drug Repurposing Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Drug Repurposing Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Drug Repurposing Product and Service
-
14.4 Biovista
-
14.4.1 Biovista Company Details
-
14.4.2 Biovista Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biovista Drug Repurposing Product and Service
-
14.5 NuMedii
-
14.5.1 NuMedii Company Details
-
14.5.2 NuMedii Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 NuMedii Drug Repurposing Product and Service
-
14.6 Astellas Pharma
-
14.6.1 Astellas Pharma Company Details
-
14.6.2 Astellas Pharma Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astellas Pharma Drug Repurposing Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Drug Repurposing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drug Repurposing
-
Figure Drug Repurposing Picture
-
Table Global Drug Repurposing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug Repurposing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug Repurposing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drug Repurposing Consumption by Country (2017-2022)
-
Figure United States Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Table Europe Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Figure China Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Figure Japan Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Figure India Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drug Repurposing Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Repurposing Consumption Forecast by Country (2022-2028)
-
Figure United States Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global CNS Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drug Repurposing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drug Repurposing Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Drug Repurposing Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Drug Repurposing Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drug Repurposing Product and Service
-
Table Biovista (Foundation Year, Company Profile and etc.)
-
Table Biovista Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biovista Drug Repurposing Product and Service
-
Table NuMedii (Foundation Year, Company Profile and etc.)
-
Table NuMedii Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table NuMedii Drug Repurposing Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Drug Repurposing Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Drug Repurposing Product and Service
-
